Brian Louis Cohen, M.D., M.P.H.



Similar documents
Improving access and reducing costs of care for overactive bladder through a multidisciplinary delivery model

Case Based Urology Learning Program

A major strength of the program is the diversity of experience and expertise within the faculty.

Adult Urodynamics: American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Guideline

MANAGEMENT OF SLING COMPLICATIONS IN FEMALES. Jorge L. Lockhart M.D. Program Director Division of Urology University of South Florida

7. Prostate cancer in PSA relapse

Female Urinary Incontinence

Urinary Incontinence in Women. Susan Hingle, M.D. Department of Medicine

Radiation Therapy for Prostate Cancer: Treatment options and future directions

SOGC Recommendations for Urinary Incontinence

Regain Control of Your Active Life Treatment Options for Incontinence and Pelvic Organ Prolapse

Overactive Bladder (OAB) Content of the lecture

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Female Urinary Disorders and Pelvic Organ Prolapse

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

9/24/2015. Incontinence and Prolapse 2015 Primary Care Update CME Symposium. Objectives. Mark Memo, DO, FACS NEO Urology September 25-27

It usually presents with a sudden urge to urinate that is very difficult to delay and may be associated with leakage. Other features include:

Stress Urinary Incontinence & Sexual Function

Urodynamics in Neuro-Urology

The Business of Prostate Cancer Care: A Clinician-Researcher s Perspective

Comprehensive Adult & Pediatric Urology

Dr Eva Fong. Urologist Auckland

ANDREW CALLAWAY JAMES, MD

Urinary Incontinence FAQ Sheet

KELLI DEWITT WHITEHEAD, RN, MS, ARNP

Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery

Mixed urinary incontinence - sling or not sling

Lower Urinary Tract Symptoms (LUTS) in Middle-Aged and Elderly Men

Management of Neurogenic Bladder Disorders

Position Statement on Mesh Midurethral Slings for Stress Urinary Incontinence

Overactive bladder syndrome (OAB)

botulinum toxin type A 50, 100, 200 Allergan units/vial (Botox ) SMC No. (916/13) Allergan Ltd

Classification of Mixed Incontinence

Overactive bladder (OAB) is a

OAB (Overactive Bladder)

OVERACTIVE BLADDER DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER IN ADULTS:

Gwen Griffith Clinical Nurse Specialist Bolton NHS foundation Trust

Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding

TIBIAL NERVE STIMULATION: ONE OF SEVERAL NEW OPTIONS FOR THE MANAGEMENT OF OVERACTIVE BLADDER IN WOMEN

Female Urinary Incontinence

PSA Screening for Prostate Cancer Information for Care Providers

Historical Basis for Concern

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011

Guidelines on Neurogenic Lower Urinary Tract Dysfunction

1 in 3 women experience Stress Urinary Incontinence.

LOSS OF BLADDER CONTROL IS TREATABLE TAKE CONTROL AND RESTORE YOUR LIFESTYLE

Prostate Cancer Treatment Comparison

Urinary Incontinence: an overview!! Neil Harris Consultant Urological Surgeon, Leeds

Bladder Health Promotion

Considering a Subspecialty in ObGyn? Advance your Skills and Knowledge! Subspecialty Training Programs in Obstetrics and Gynaecology

Postoperative. Voiding Dysfunction

URO. 19/20 March th International Workshop. Madrid

FEMALE INCONTINENCE REVIEW

PROCEEDINGS INCIDENCE AND PREVALENCE OF STRESS URINARY INCONTINENCE * Ananias C. Diokno, MD ABSTRACT

Overactive bladder and urgency incontinence

CURRICULUM VITAE. PRESENT TITLE: Associate Professor and Associate Director, Residency Program

Urinary Incontinence. Causes of Incontinence. What s Happening?

University of Florida, Gainesville, Fl: Completed May 2005 Bachelors of Health Science Specialization: Rehabilitation

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

URINARY INCONTINENCE IN WOMEN

National Hospital for Neurology and Neurosurgery

Treating Prostate Cancer

COMPLICATIONS OF FISTULA REPAIR SURGERY. Sherif Mourad

Combined Harvard Urologic Oncology Fellowship Program

MEDICAL STAFF DIRECTORY

Urinary Incontinence. Anatomy and Terminology Overview. Moeen Abu-Sitta, MD, FACOG, FACS

Urinary incontinence poses major medical

URINARY INCONTINENCE

Radiation Therapy for Prostate Cancer

Does early return to physical activity affect the cure rates for mid-urethral sling surgery?

Curriculum Vitae. Name: Dr. Rodney B. Young, III M.D.

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

Management of spinal cord compression

Bladder Health Promotion

Does my patient need more therapy after prostate cancer surgery?

Learning Resource Guide. Understanding Incontinence Prism Innovations, Inc. All Rights Reserved

Department of Geriatrics

Transcription:

Brian Louis Cohen, M.D., M.P.H. MEDICAL TRAINING Fellowship in Female Urology, Voiding Dysfunction, and Reconstructive Urology Anticipated, July 2007 June 2008 Residency in Urology, July 2003 June 2007 Internship in General Surgery, June 2002 June 2003 PUBLICATIONS Cohen BL, Barboglio P, Gousse AE. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med 2008 June; 5(6): epub available. LeBoeuf L, Cohen BL, Gousse AE. Multiple Sclerosis chapter in Textbook of the Neurogenic Bladder. Informa Healthcare in press. Cohen BL, Gousse AE. Current Techniques for Vesico-Vaginal Fistula Repair: Surgical Pearls to Optimize Cure Rate. Curr Urol Reports 2007 Sept; 8(5): 413-418. Cohen BL, Rivera R, Barboglio P, Gousse AE. Safety and tolerability of sedation-free flexible cystoscopy for intra-detrusor botulinum toxin A injection. J Urol 2007 Mar; 177(3):1006-1010. Golshani R, Hautmann SH, Estrella V, Cohen BL, Kyle CC, Manoharan M, Jorda M, Soloway MS, Lokeshwar VB. HAS1 expression in bladder cancer and its relation to urinary HA test. Int J Cancer. 2007 Jan 17; 120(8):1712-1720. Cohen BL, Tunuguntla HSGR, Gousse AE. Predictors of success for first-stage InterStim neuromodulation: motor versus sensory response. J Urol. 2006 Jun; 175(6):2178-2180 Cohen BL, Gomez P, Omori Y, Duncan RC, Soloway MS, Lokeshwar VB, Lokeshwar BL. Cyclo-oxygenase-2 expression is an independent predictor of prostate cancer recurrence. Int J Cancer. 2006 Mar; 19(5):1082-1087.

Mohler JL, Gaston KE, Moore DT, Schell MJ, Cohen BL, Weaver C, Petrusz P. Racial differences in prostate androgen levels in men with clinically localized prostate cancer. J Urol. 2004 Jun; 171(6 Pt 1):2277-80. PRESENTATIONS Cohen BL, Barboglio P, Gousse AE. Can we predict who will respond to botulinum toxin-a injections for idiopathic overactive bladder? Society for Urodynamics and Female Urology Meeting (Miami, FL), March 2008, podium Cohen BL, Barboglio P, Rodriguez D, Gousse AE. Preliminary results of a dosefinding study for botulinum toxin-a in patients with idiopathic overactive bladder: 100 vs. 150 units. Society for Urodynamics and Female Urology Meeting (Miami, FL), March 2008, podium Cohen BL, Barboglio P, Gousse AE. Idiopathic overactive bladder responders to Botox maintain therapeutic benefit with re-injection over 3 year period. North Central Section AUA Meeting (Hollywood, FL), November 2007, podium Cohen BL, Barboglio P, Gousse AE. What is the predictive value of urodynamics when compared to clinical history? International Continence Society Meeting (Rotterdam, the Netherlands), August 2007: Neuro Urol and Urodyn 2007 Aug; 26(5):616-617. Abstract 12 ICS 2007. Cohen BL, Barboglio P, Gousse AE. Urodynamic incontinence correlates with sexual dysfunction in female patients with voiding dysfunction. International Continence Society Meeting (Rotterdam, the Netherlands), August 2007: Neuro Urol and Urodyn 2007 Aug; 26(5):726-727. Abstract 86 Gousse AE, Cohen BL, Rodriguez D, Barboglio P. Botulinum toxin A 100 vs. 150 units in idiopathic overactive bladder patients: is there any difference? International Continence Society Meeting (Rotterdam, the Netherlands), August 2007: Neuro Urol and Urodyn 2007 Aug; 26(5):711-712. Abstract 100 ICS 2007. Gousse AE, Cohen BL, Rodriguez D, Barboglio P. Botulinum toxin A: Intradetrusor re-injections in idiopathic overactive bladder every 6 months 3 years follow-up. International Continence Society Meeting (Rotterdam, the Netherlands), August 2007: Neuro Urol and Urodyn 2007 Aug; 26(5):728-729. Abstract 102 ICS 2007.

Gousse AE, Cohen BL, Rodríguez D, Barboglio P. Correlation between voiding diary and the UDI-6 validated questionnaire in idiopathic OAB patients subjected to a Repeated Botox injection protocol. American Urologic Association Meeting (Anaheim, CA) May 2007 podium : J Urol 2007 Apr; 177(4) Supplement:557. Cohen BL, Barboglio P, Gousse AE. The impact of anterior pelvic organ prolapse on female sexual function using validated instruments. American Urologic Association Meeting (Anaheim, CA) May 2007 podium : J Urol 2007 Apr; 177(4) Supplement:422. Barboglio P, Cohen BL, Gousse AE. The Urinary Distress Inventory questionnaire (UDI-6) and Clinical Findings: Do they Correlate in our Office American Urologic Association Meeting (Anaheim, CA) May 2007 moderated poster: J Urol 2007 Apr; 177(4) Supplement:486. Cohen BL, Barboglio P, Gousse AE. The impact of overactive bladder and urinary incontinence on female sexual function using validated instrument. Society of Urodynamics and Female Urology Meeting (San Diego, CA), February 2007 podium Cohen BL, Barboglio P, Gousse AE. Effect of external beam radiotherapy versus brachytherapy on artificial urinary sphincter (AMS 800) in prostate cancer patients: Is outcome affected? Society of Urodynamics and Female Urology Meeting (San Diego, CA), February 2007 moderated poster Gousse AE, Cohen BL, Barboglio P. Scheduled repeated Botox injections for idiopathic OAB: Evaluating therapeutic time. Society of Urodynamics and Female Urology Meeting (San Diego, CA), February 2007 moderated poster Gousse AE, Cohen BL, Barboglio P.Botox repeated injections: Side effects and complications. Society of Urodynamics and Female Urology Meeting (San Diego, CA), February 2007 moderated poster Cohen BL. Radiofrequency ablation vs. cryotherapy for small renal masses. Florida Urologic Society (Orlando, FL), August 2006 resident debate Cohen BL, Gomez P, Omori Y, Duncan RC, Soloway MS, Lokeshwar VB, Lokeshwar BL. COX-2 expression predicts biochemical failure in prostate cancer patients: An 11-year retrospective study. AUA Southeastern Section Meeting (Rio Grande, Puerto Rico), March 2006 podium AUA Society of Basic Urologic Research (Linthicum, MD), August 2005 poster Sylvester Comprehensive Cancer Center Resident and Fellow Research Poster Competition (Miami, FL), 2005 poster

Cohen BL, Rivera R, Barboglio P, Gousse AE. Use of a validated pain instrument to assess pain tolerance during flexible endoscopy for intra-detrusor botulinum toxin-a injection. AUA Southeastern Section Meeting (Rio Grande, Puerto Rico), March 2006 podium. Societe Internationale d Urologie Meeting (Cape Town, South Africa), November 2006 podium : Urology 2006 Nov; 68 Supplement 1:44. Cohen BL, Manoharan M, Soloway MS. Orthotopic neobladder reconstruction following cystectomy for bladder cancer: Is adjuvant chemotherapy safe? Society of Urologic Oncology Winter Meeting (Bethesda, MD), December 2005 poster EDUCATION University of North Carolina at Chapel Hill School of Medicine M.D., May 2002 University of North Carolina at Chapel Hill School of Public Health M.P.H. in Epidemiology, May 2002 University of North Carolina at Chapel Hill B.S. in Mathematics with highest distinction, May 1997 HONORS AND AWARDS University of Miami Jackson Memorial Hospital David Weinstein Urodynamics Award, June 2007 Awarded for highest Urology In-service score for neurourology, urodynamics and voiding dysfunction Florida Urologic Society Annual Meeting Resident Debate 3 rd prize, 2006 Awarded 3 rd place in resident debates for topic Radiofrequency ablation vs. cryotherapy for small renal masses. AUA Society of Basic Urologic Research Travel Award, August 2005 Poster COX-2 expression predicts biochemical failure in prostate cancer patients: An 11-year retrospective study. Sylvester Comprehensive Cancer Center Resident and Fellow Research Poster Competition, 2005 Awarded third prize for research on COX-2 expression in prostate cancer

University of North Carolina at Chapel Hill School of Medicine Cofounders Award Research Grant, 2000-2002 Awarded for research project on prostate cancer in Department of Urology NIH Summer Research Grant, 1998 Performed research on acute lung injury during sepsis in Department of Surgery Holderness Fellowship, 1998-1999 Year-long award to support research in Department of Surgery UNC Student Stores Merit Award, 1998 & 1999 Awarded to students receiving grade of Honors for first and second year medical students PROFESSIONAL MEMBERSHIPS American Urological Association 2003-present Florida Urologic Society 2003-present American Medical Association 1997-2002 North Carolina Medical Society 1997-2002